Journal
ANAESTHESIA
Volume 72, Issue 2, Pages 233-247Publisher
WILEY
DOI: 10.1111/anae.13773
Keywords
anaemia; iron; pre-operative assessment; transfusion
Categories
Funding
- Pharmacosmos
- Vifor Pharma
- Syner-Med, UK
- Vifor Pharma, Switzerland
- CSL Behring
- Gauss Surgical
- Masimo
- HbO2 Therapeutics
- B. Braun
- Fresenius Kabi
- Sorin Group
- Roche
- Abbott
- Ethicon
- Sanofi Aventis Baxter Healthcare
- Sangart Inc.
- Alliance Pharmaceutical Corp.
- Swiss National Science Foundation, Berne, Switzerland
- Ministry of Health (Gesundheitsdirektion) of the Canton of Zurich, Switzerland
- Swiss Society of Anesthesiology and Reanimation (SGAR), Berne, Switzerland
- Swiss Foundation for Anesthesia Research, Zurich, Switzerland
- Vifor SA, Villarssur-Glane, Switzerland
- Novo Nordisk
- LFB Biomedicaments
Ask authors/readers for more resources
Despite current recommendations on the management of pre-operative anaemia, there is no pragmatic guidance for the diagnosis and management of anaemia and iron deficiency in surgical patients. A number of experienced researchers and clinicians took part in an expert workshop and developed the following consensus statement. After presentation of our own research data and local policies and procedures, appropriate relevant literature was reviewed and discussed. We developed a series of best-practice and evidence-based statements to advise on patient care with respect to anaemia and iron deficiency in the peri-operative period. These statements include: a diagnostic approach for anaemia and iron deficiency in surgical patients; identification of patients appropriate for treatment; and advice on practical management and follow-up. We urge anaesthetists and peri-operative physicians to embrace these recommendations, and hospital administrators to enable implementation of these concepts by allocating adequate resources.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available